AVentures Capital Invests in Viseven, a Fast-Growing Digital Solution Provider

for the Pharmaceutical and Life Sciences Enterprise Companies

AVentures Capital invested in Viseven, a fast-growing digital solution provider for the world’s
largest pharmaceutical and life sciences players, and became a minority shareholder. Viseven
provides full-cycle digital multichannel solutions for life sciences and pharmaceutical industries.

Kyiv, Ukraine, June 03, 2019 --(PR.com)-- AVentures Capital invested in Viseven, a fast-growing digital
solution provider for the world's largest pharmaceutical and life sciences players, and became a minority
shareholder.

Viseven provides full-cycle digital multichannel solutions for life sciences and pharmaceutical industries.
With 10 years' experience in interactive eDetailing services (digitization of sales content on a mobile
device), the company addresses all aspects of the content lifecycle from concept and materials to smooth
integration with the clients' CRM system. Viseven also offers a powerful SaaS solution for content
creation and management - eWizard platform, the only platform with automatic email publishing to
Salesforce Marketing Cloud. Viseven is a global company with EU headquarters, functional offices in the
USA and Canada, and delivery hub in Ukraine manages worldwide cooperation with market leaders such
as Novo Nordisk, Biogen, Abbott, Bayer.

Nataliya Andreychuk, CEO and one of the co-founders of Viseven: “Over the years Viseven has
continuously empowered its global customers with multichannel capabilities, reducing production costs
and enabling them to deliver personalized content to the audience across the whole spectrum of channels
with full cycle digital pharma solutions. We are set to continue rapid growth and invest in our staff and
services and look forward to building a strong globally-known company together with our partners.”

"Viseven is one of the fastest growing vertically-focused digital businesses in CEE. We were impressed
by the Viseven's team, their energy and ambition to become a large global enterprise. Knowing the level
of their expertise, I have no doubts about their potential to become a leading player in pharma vertical in
enterprise segment globally," said Yevgen Sysoyev, managing partner of AVentures Capital who joined
Viseven Board as a Director.

AVentures Capital is a leading investment and M&A advisory firm that leverages R&D in Ukraine and
CEE founded in 2012. The firm invests and provides M&A advisory services across IT outsourcing,
software, e-commerce, cloud services, mobile technology, IoT and other sectors. AVentures Capital has
over 15 companies in its portfolio that operate in the US and EU market and leverage R&D in Ukraine
and CEE.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
AVentures Capital
Yuliya Sychikova
+380950930711
Contact via Email
aventurescapital.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/786379

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use